Snoeks, Thomas J A <br/><br/>
2-methoxyestradiol analogue ENMD-1198 reduces breast cancer-induced osteolysis and tumor burden both in vitro and in vivo.  [electronic resource] 

 -  Molecular cancer therapeutics  May 2011 
 - 874-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-10-0997  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Bone Neoplasms--pathology<br/>Bone Resorption--drug therapy<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Estrenes--pharmacology<br/>Female<br/>Humans<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Neovascularization, Pathologic--drug therapy<br/>Osteoclasts--drug effects<br/>Osteolysis--drug therapy<br/>Pregnancy<br/>Tumor Burden--drug effects